文献速递肝病

重型慢加急性肝衰竭患者肝移植前后生存相关因素分析

Factors Associated with Survival of Patients With Severe Acute-On-Chronic Liver Failure Before and After Liver Transplantation.
PubMed 文献 · Gastroenterology · 2018-12-18

基于美国器官共享联合网络2005至2016年数据,分析100,594例等待名单患者与50,552例肝移植受者,发现ACLF-3患者无论MELD-Na评分高低均更易死亡或退出等待名单,肝移植可提高生存几率,尤其在列入等待名单30天内完成移植。

要点

  • ACLF-3患者无论MELD-Na评分如何,等待名单死亡或退出风险均高于其他ACLF组。
  • ACLF-3且MELD-Na低于25者28天死亡或退出比例达43.8%。
  • 肝移植时机械通气与使用边缘供体与移植后1年生存降低独立相关。

核心结论

  • ACLF-3患者在肝移植等待名单上死亡率高,即使MELD-Na评分较低。
  • 肝移植可提高这些患者的生存几率,尤其在列入等待名单30天内完成移植。

研究设计与样本

  • 分析美国器官共享联合网络(UNOS)2005年至2016年登记数据,纳入等待名单患者100,594例和肝移植受者50,552例。
  • ACLF依据欧洲肝病学会慢加急性肝衰竭标准识别,采用竞争风险回归、Kaplan-Meier分析和Cox比例风险回归评估结局。

主要发现

  • 与其他ACLF组相比,ACLF-3患者无论MELD-Na评分如何均更易死亡或退出等待名单。
  • ACLF-3且MELD-Na评分低于25的患者28天死亡或退出比例为43.8%。
  • 肝移植时机械通气与移植后1年生存独立相关(HR 1.49;95%CI 1.22-1.84)。
  • 供体风险指数高于1.7与移植后1年生存独立相关(HR 1.22;95%CI 1.09-1.35)。
  • 列入等待名单30天内行肝移植与移植后1年生存独立相关(HR 0.89;95%CI 0.81-0.98)。

临床怎么用

  • 作者认为,部分ACLF-3患者无论MELD-Na评分如何结局均较差,肝移植可提高其生存几率,尤其在列入等待名单30天内完成移植。
  • 作者认为,肝移植时机械通气和使用边缘器官与死亡风险增加相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Liver transplantation for patients with acute-on-chronic liver failure (ACLF) with 3 or more failing organs (ACLF-3) is controversial. We compared liver waitlist mortality or removal according to model for end-stage liver disease (MELD) score vs ACLF category. We also studied factors associated with reduced odds of survival for 1 year after liver transplantation in patients with ACLF-3. METHODS: We analyzed data from the United Network for Organ Sharing (UNOS) from 2005 through 2016. We identified patients who were on the waitlist (100,594) and those who received liver transplants (50,552). Patients with ACLF were identified based on the European Association for the Study of the Liver-chronic liver failure criteria. Outcomes were evaluated with competing risks regression, Kaplan-Meier analysis, and Cox proportional hazards regression. RESULTS: Patients with ACLF-3 were more likely to die or be removed from the waitlist, regardless of MELD-sodium (MELD-Na) score, compared with the other ACLF groups; the proportion was greatest for patients with an ACLF-3 score and MELD-Na score below 25 (43.8% at 28 days). Mechanical ventilation at liver transplantation (hazard ratio [HR] 1.49; 95% confidence interval [CI] 1.22-1.84), donor risk index above 1.7 (HR 1.22; 95% CI 1.09-1.35), and liver transplantation within 30 days of listing (HR 0.89; 95% CI 0.81-0.98) were independently associated with survival for 1 year after liver transplantation CONCLUSIONS: In an analysis of data from the UNOS registry, we found high mortality among patients with ACLF-3 on the liver transplant waitlist, even among those with lower MELD-Na scores. So, certain patients with ACLF-3 have poor outcomes regardless of MELD-Na score. Liver transplantation increases odds of survival for these patients, particularly if performed within 30 days of placement on the waitlist. Mechanical ventilation at liver transplantation and use of marginal organs were associated with increased risk of death.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Sundaram V, Jalan R, Wu T, et al. Factors Associated with Survival of Patients With Severe Acute-On-Chronic Liver Failure Before and After Liver Transplantation. Gastroenterology. 2018. PMID: 30576643. doi:10.1053/j.gastro.2018.12.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。